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Neuroinflammation can be monitored using fluorine-19 (19F)-containing nanoparticles and 19F MRI. 
Previously we studied neuroinflammation in experimental autoimmune encephalomyelitis (EAE) using 
room temperature (RT) 19F radiofrequency (RF) coils and low spatial resolution 19F MRI to overcome 
constraints in signal-to-noise ratio (SNR). This yielded an approximate localization of inflammatory 
lesions. Here we used a new 19F transceive cryogenic quadrature RF probe (19F-CRP) that provides 
the SNR necessary to acquire superior spatially-resolved 19F MRI. First we characterized the signal-
transmission profile of the 19F-CRP. The 19F-CRP was then benchmarked against a RT 19F/1H RF coil. For 
SNR comparison we used reference compounds including 19F-nanoparticles and ex vivo brains from EAE 
mice administered with 19F-nanoparticles. The transmit/receive profile of the 19F-CRP diminished with 
increasing distance from the surface. This was counterbalanced by a substantial SNR gain compared 
to the RT coil. Intraparenchymal inflammation in the ex vivo EAE brains was more sharply defined 
when using 150 μm isotropic resolution with the 19F-CRP, and reflected the known distribution of EAE 
histopathology. At this spatial resolution, most 19F signals were undetectable using the RT coil. The 19F-
CRP is a valuable tool that will allow us to study neuroinflammation with greater detail in future in vivo 
studies.
Central nervous system (CNS) inflammation, as occurs in multiple sclerosis (MS), involves immune cell recruit-
ment from the periphery into the CNS, resulting in tissue destruction and neurodegeneration1. During active 
disease, a massive infiltration of immune cells is predominant, particularly around white matter lesions. T cells 
find their way into the white matter via a disruption of the blood brain barrier2. In MS, T cells may also enter 
the CNS grey matter such as the cerebral cortex via the meninges3, 4. Even in the cerebellum, extensive grey 
matter pathology in secondary progressive MS is linked to inflammation of the subarachnoid space5. Studies 
of the animal model of MS, experimental autoimmune encephalomyelitis (EAE), have helped identify mecha-
nisms of cell migration between the periphery, CNS and lymphatic system during neuroinflammation6–8. This is 
a topic of active interest, with divergent views regarding immune cell entry and exit in the CNS (inside-out versus 
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outside-in hypotheses) in MS9, 10. Therefore there is an acute need for more precise and non-invasive methods 
that support longitudinal studies of inflammatory cell migration during disease progression to resolve some of 
the discrepancies in the literature.
Previously we studied immune cell infiltration in EAE brains using fluorine-19 (19F)-loaded nanoparticles 
(NPs) and a room temperature (RT) dual-tuned 19F/1H radio frequency (RF) volume resonator11. Intravenously 
administered NPs are taken up by inflammatory cells during their migration from the systemic circulation into 
the inflamed organ11–17. Although tracking of inflammation following intravenous 19F-NP administration is one 
application for 19F MRI, several other state-of-the-art applications for 19F imaging exist. These include in vivo 
tracking of cell therapies labeled in culture with 19F-NPs prior to their adoptive transfer18–20 and intracellular 
oximetry using 19F-NP emulsions21 to study changes in pO2 in tumor cells during therapy22.
One major limitation of 19F MRI is the low signal-to-noise ratio (SNR). The acquisition method is one aspect 
of 19F MRI that influences SNR. SNR efficiency of the most commonly used acquisition methods — RARE (Rapid 
Acquisition with Relaxation Enhancement), UTE (Ultra-short Echo Time), and bSSFP (Balanced Steady-State 
Free Precession) — depends on the T1 and T2 values of the particular 19F compound studied23. For most T1 and 
T2 combinations, especially those pertaining to intracellular 19F-NPs, bSSFP and 3D RARE sequences have the 
highest SNR sensitivity. However, while bSSFP often has a higher SNR efficiency, it is not always the method of 
choice due to the high RF energy deposition associated with longer acquisition times, and pronounced banding 
artifacts. The SNR and the sensitivity of the radio frequency (RF) probe used are main determinants that dictate 
the level of spatial resolution. Factors to be kept in mind when designing a probe include the geometry, the filling 
factor and the homogeneity of the B1+ transmit field.
The SNR constraint limited spatial resolution to approximately 600 μm when detailing the dynamics of 
inflammation during EAE11. Given this limited precision, the location of inflammatory cells within the brain was 
not sharply defined. To overcome the sensitivity constraints in 19F MR and improve detail of inflammatory cell 
location, we applied the concept of cryogenically-cooling RF coil hardware to improve SNR by reducing thermal 
noise. Until now this technology has been available only for 1H, 13C and 31P small animal MRI. Here we made 
use of the first 19F transceive cryogenically-cooled RF probe (19F-CRP) to substantially boost SNR beyond that of 
available RT coils, thus facilitating the acquisition of better spatially-resolved images. In this study we evaluated 
the advantages and disadvantages of the 19F-CRP for imaging neuroinflammation.
Methods
Radio frequency coils. The performance of a novel transceive 19F cryogenic quadrature RF surface probe 
at 9.4T (19F-CRP, f ~ 376 MHz) was compared to a dual-tunable 19F/1H volume resonator (φin = 18.4 mm, 
ltotal = 39 mm), previously developed for imaging mouse brain inflammation11. The 19F-CRP has a similar geom-
etry to the existing Bruker 1H quadrature CryoProbes24. The rectangular transceive copper coil elements are 
overlapping side-by-side on a cylindrical surface (r ~ 11 mm, axis parallel to the main magnetic field direction). 
The outer dimensions (O.D.) of one coil element are: 16 × 20 mm2 [arc length (φ × z)] and the total O.D. are: 
27 × 20 mm2 [φ × z]. The 19F-CRP operates at ~28 K with a dual cooled preamplifier at the base running at ~77 K. 
Constant cooling is ensured by a closed loop system connected to a remote cryo-cooler. The RF coil is thermally 
insulated by a vacuum separating it from the surrounding ceramic finger (Fig. 1A). The outer surface of the RF 
finger is equipped with a temperature sensor and kept at a temperature of choice (35 °C) using a resistive heater. 
The SNR gain of this CRP relative to a RT coil with similar geometry is expected to be comparable to existing 
400 MHz proton CryoProbes24, 25.
Experimental setup. To evaluate the 19F-CRP performance, three different phantom-setups were prepared 
(Fig. 1B):
Setup 1 (high concentration 19F): a 10 ml syringe (inner/outer diameter = 17.0 mm/15.5 mm) for the 19F-CRP 
and a 5 ml syringe (I.D./O.D. = 13.5/12.0 mm) for the 19F/1H RT-coil, both containing the same 19F reference com-
pound to study B1
+ and compare spatial SNR. The reference compound was 33% v/v 2,2,2-Trifluoroethanol (TFE, 
Sigma-Aldrich, Germany) in water.
Setup 2 (19F nanoparticles): NMR tubes (I.D./O.D. = 4.0/5.0 mm) containing different concentrations of 
perfluoro-15-crown-5-ether (PFCE) loaded nanoparticles to compare 19F signal sensitivity as a function of the 
number of 19F atoms. Nanoparticles were prepared by emulsifying 1200 mM PFCE (Fluorochem, UK) with 
Pluronic F-68 (Sigma-Aldrich, Germany) using a titanium sonotrode (Sonopuls GM70, Bandelin, Germany) 
as previously described26. The PFCE nanoparticle stock was then diluted to 25 mM, 50 mM, 100 mM, 200 mM, 
400 mM and 600 mM nanoparticle suspensions. NMR tubes containing different nanoparticle concentrations 
were placed below the CRP using a spacer of 0.75 mm thickness to mimic the distance of the mouse brain from 
the CRP surface in in vivo applications.
Setup 3 (mouse brain): Ex vivo tissues from fixed EAE mice embedded in 15-ml tubes, for comparing 19F sig-
nal sensitivity and anatomical detail. All experiments were conducted in accordance with procedures approved by 
the Animal Welfare Department of the State Office of Health and Social Affairs Berlin (LAGeSo), and conformed 
to national and international guidelines to minimize discomfort to animals (86/609/EEC). EAE was induced as 
described previously11 in SJL/J mice (n = 6, female, 6–8 weeks old). Five days following EAE induction, mice were 
administered nanoparticles (10µmol PFCE) intravenously each day for 5 d as described previously11. EAE mice 
were transcardially perfused with 20 ml PBS followed by 20 ml 4% paraformaldehyde (PFA) following terminal 
anesthesia. Mice were cleared from external pelt, extremities, and abdominal tissues. Brain, spinal cord and neck 
lymphoid organs were preserved in situ within the skull and vertebral column. The tissues were transferred into a 
15 ml tube filled with 4% PFA and stored at 4 °C.
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MRI Methods and Data Analysis. All experiments were carried out on a 9.4 T small animal MR system 
(BioSpec 94/20, Bruker BioSpin MRI, Ettlingen, Germany) operating at 400 MHz (1H) and 376 MHz (19F).
Transmit Field Characteristics. Using a 15 ml tube containing 33% TFE in water (Setup 1), we acquired 
2D-FLASH images (TR = 20 s, TE = 4.9 ms, FOV = (20 × 20) mm2, matrix = 256 × 256, 1 slice of 4 mm thickness, 
averages = 1, TA = 1 h 25 min) with nominal excitation flip angles α = 60° and 2α = 120° and calculated the actual 
flip angles (FA) using the double-angle method27, 28:
= α αFA acos(SI /(2SI )) (1)2
with SIα and SI2α being the signal intensities obtained with α and 2α. FA maps were normalized to a nominal 
angle of 90° by multiplying by the factor 90°/α.
SNR assessment in phantoms. To measure the spatial distribution of SNR at increasing distances from the 
19F-CRP surface, a high-concentration 19F phantom (Setup 1) and an axial 2D-RARE scan (TR = 10 s, TE = 6.2 ms, 
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Figure 1. 19F Cryogenic Radiofrequency Probe design and experimental setup. (A) Side view of the 19F-CRP 
showing its geometry including external protective cylinder and an inner ceramic probe head that encloses 
the loop coil elements (not shown). The inner diameter dimension for the inner ceramic structure is shown 
in the cross-sectional view (right). (B) Three different experimental setups that were used to assess the 19F-
CRP quality. Shown are Setup 1 for the high concentration 19F phantom (upper panel), Setup 2 for the 19F 
nanoparticle phantoms (middle panel) and Setup 3 for the mouse brain phantom (lower panel). The dimension 
of the phantom setups are to scale with the dimensions of both 19F-CRP and RT coil and an anatomic reference 
is shown on the right for comparison. The nanoparticles used in this study had the following physical 
characteristics: Z-average diameter = 164 nm, PdI = 0.06, z-Potential = 0.19 mV.
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ETL = 256, FOV = (25.6 × 25.6) mm2, matrix = 256 × 256, averages = 100, TA = 17 m) was used. To quantify and 
compare SNR in a way more relevant for brain inflammation, we measured SNR as a function of the number of 19F 
atoms using phantoms containing different concentrations of 19F nanoparticles (Setup 2, Fig. 1B). Measurements 
involved 2D-RARE scans (TR = 3000 ms, TE = 10.8 ms, ETL = 8, FOV = (10 × 10)mm2, matrix = 96 × 96, aver-
ages = 1, TA = 36 s) with varying slice thicknesses: 0.4/1.0/1.2/2.0/3.6/4.7/6.0 mm to measure SNR as a function 
of the number of 19F atoms.
SNR was calculated by dividing signal Sm from magnitude images by background standard deviation σm, 
and corrected to compensate for the non-Gaussian distribution29. For single channel RF coils, intensity values 
of MR images follow a Rician distribution30, 31. For a two-receiver, quadrature system (19F-CRP), they follow a 
non-central chi distribution32. We estimated the true SNR from the Sm and background σm using
SNR S S
f S
c
( , )
1/ (2)
m
m
S m m
σ σ
σ
= = ⋅
σ
where cσ is 0.655 (Rician) and 0.687 (chi), and the correction function fS is derived from the respective distribu-
tion’s mean30, 32. For Setup 2, a single SNR value was determined from the mean signal intensity over a central 
circular region-of-interest covering ~90% of pixels. The number of atoms per image pixel was estimated from 
nanoparticle concentration and voxel size.
Ex vivo mouse brain 19F and 1H MRI (Setup 3). 19F MR images of the EAE mouse brain were acquired using 
3D-RARE: TR = 800 ms, TE = 5.1 ms, ETL=33, FOV=(30 × 20 × 20) mm3, matrix = 195 × 65 × 65 zero-filled 
to 195 × 130 × 130, averages = 384, TA = 11 h. 1H MR images were acquired using 3D-FLASH (TR = 50 ms, 
TE = 12.5 ms, FOV = (30 × 20 × 20) mm3, matrix = 384 × 256 × 284 zero-filled to 768 × 512 × 512, averages = 2, 
TA = 6 h 3 min). 19F MR images from the 19F-CRP were registered with those from the 19F/1H RT-coil. Since 
the 19F-CRP has no 19F/1H dual resonant capacity, we registered the CRP 19F images onto the RT 19F images in 
order for both 19F images (RT and CRP) to be spatially aligned with the RT 1H images. For this, three repetitions 
of the RT 19F scan were averaged to achieve sufficient 19F signal with the RT-coil and an effective registration. 
Co-registration was applied using affine diffeomorphic image registration (12 degrees of freedom) by explicit 
B-spline regularization33, which is part of the Advanced Normalisation Tool (ANTs)34. Registration of the Allen 
brain atlas35 to the 1H image was achieved as follows: (1) 1H image and atlas template were segmented in grey 
matter (GM), white matter (WM) and cerebrospinal fluid (CSF) probability maps with SPMMouse (http://www.
spmmouse.org/)36, (2) two synthetic images were generated with signal intensity in each voxel I(x,y,z) = 1.0 × GM 
(x y, z) + 2.0 × WM + 4.0 × CSF, i.e. one registered with the 1H image and one registered with the atlas, (3) both 
synthetic images were warped to the 1H image using nonlinear B-spline registration in ELASTIX (http://elastix.
isi.uu.nl/)37. Raw 1H MRI files were converted to NIFTI-format and brains segmented with ITK-SNAP version 
3.4.038. For 2D representation of 19F/1H MRI we performed overlays of the raw 19F MR data with SNR-based 
scaling using Matlab. For 3D representation we used ImageJ (National Institutes of Health, USA, http://imagej.
nih.gov/ij).
Results
Transmit field characteristics of the 19F-CRP. Since transceive surface coils do not achieve a spatially 
uniform excitation like volume resonators24, we assessed the B1+ characteristics of the 19F-CRP (Fig. 2A) and 
quantified changes in FA. A profile plot of the FA along the vertical axis (Fig. 2B) reveals a strong FA decrease 
with increasing distance from the CRP surface. Across a distance of 10.4 mm the measured FA varies between 
152° and 0°. From the nominal FA of 90° the actual FA deviates up to 50% within a range of 6.0 mm (1.5–7.5 mm 
from CRP surface).
SNR assessment in phantoms. To study the SNR performance of the 19F-CRP, we first used a high 19F 
concentration (33% TFE solution) (Fig. 3A). The transversal spin-echo 19F MR images demonstrate a homog-
enous SNR for the RT coil and a spatially varying SNR for the CRP (Fig. 3A). We adjusted the reference pulse 
Figure 2. Transmission B1+ Field (B1+) for the 19F-CRP. (A) Flip angle maps acquired in vertical and transversal 
orientation using a high concentration 19F phantom (Setup 1). (B) Profile plot of the FA along the vertical axis 
that depicts the change in FA with increasing distance to the CRP surface.
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power in order to avoid substantial signal loss at the dorsal side of the brain. Using this reference pulse power, the 
SNR reached its peak at a distance of 2.4 mm, where it was ~15-fold higher than the SNR of the RT coil (Fig. 3B). 
The SNR of both RF coils are approximately equal at a distance of 8.6 mm from the CRP.
We next investigated the detection limits for both coils by measuring 19F nanoparticles, as a biologically rel-
evant preparation. We employed concentrations of PFCE (25 mM–200 mM) yielding a range of 1015–1018 19F 
atoms per voxel (Fig. 4A). Qualitatively, we reached a detection limit in the order of 1015 fluorine atoms using 
the 19F-CRP, compared to 1016 fluorine atoms with the 19F RT-coil. Specifically, an SNR of 3.0 was achieved with 
(0.1 × 0.1 × 0.4) mm³ voxels of a 25 mM PFCE concentration (equating to 5.2 × 1015 fluorine atoms) when using 
the 19F-CRP. In contrast an SNR of 2.4 was achieved with (0.1 × 0.1 × 1.2) mm³ voxels of a 100 mM PFCE con-
centration (equating to 6.2 × 1016 fluorine atoms) when using the 19F- RT-coil. In both cases the measurement 
time was 36 s. MR images with an SNR value below 2 were not sharply defined. To estimate SNR provided by the 
19F-CRP compared to the 19F/1H RT-coil, we used SNR = 2 as a cutoff equating to ~5 × 1016 (RT) and ~4 × 1015 
(CRP) fluorine atoms per voxel. Next we prepared higher concentrations of 19F nanoparticles (200 mM to 
1200 mM) to achieve SNR values well above 2, spanning a range of 1017–1019 atoms per voxel. From these experi-
ments we calculated an SNR gain of ~16 for the 19F-CRP when compared to the 19F/1H RT-coil (Fig. 4B).
High spatially-resolved 19F MRI. An important utilization of the SNR gain is to localize cell infiltrates in 
the brain with more detail. Previously areas of inflammation were detected using spatial resolutions greater than 
600 μm11. Here we exploited the superior SNR of the 19F-CRP, and used an isotropic spatial resolution of 150 μm. 
Ex vivo MR images obtained with the 19F-CRP from an exemplary EAE mouse (day 10 following EAE induction, 
score = 1.25) show a more precise distribution of intraparenchymal inflammation. At this spatial resolution, the 
majority of the 19F signals obtained by the 19F-CRP were not detected with the RT coil (Fig. 5A–C). In addition 
we show similar inflammatory patterns in a pre-symptomatic mouse, also sacrificed on day 10 following EAE 
induction (Supplementary Figure). Within the cerebellum, inflammatory infiltrates were mostly localized within 
the white matter of the arbor vitae, particularly near deep cerebellar nuclei (Fig. 5B). Clearly delineated inflamma-
tory areas were found in grey matter regions running adjacent to white matter tracts in the cerebellum (Fig. 5A). 
This is consistent with the expected patterns of inflammation in the EAE model39, 40, also as observed in our own 
prior studies11, 41, 42. Using the 19F-CRP, we also observed strong 19F signals in the cerebrum emanating from the 
striatum and pallidum appearing continuous with 19F signals from the third ventricle (Fig. 5A). Additionally, 
clear extraparenchymal meningeal inflammation could be seen, consistent with recent reports43–45. Especially 
strong inflammatory signals were observed along the dorsal surface of the brain, including meningeal regions 
lining fissures between the cerebellar lobules. These inflammatory regions extended ventrally to the prepyram-
idal fissure, parafloccular sulcus and lateral recess of the fourth ventricle. A dominant 19F signal was observed 
around the meninges lining the ventral part of the retrosplenial area of the cerebral cortex (Fig. 5B), spreading 
caudally towards the cerebellum, running in parallel to the superior sagittal sinus, and eventually the retrogle-
noid vein (Fig. 5C). In these experiments we focused on highly resolved inflammation imaging in the EAE brain, 
employing long acquisition times in order to compensate for the considerably lower 19F signal sensitivity of the 
19F/1H RT-coil. Since these acquisition times (11 h) are not applicable for in vivo studies, we performed further 
experiments in which we reduced the scan time. Upon reducing the scan time from 11 h to 0.5 h we could still 
detect 19F signals with the 19F-CRP (Fig. 6). Despite the clear differences we were nevertheless still able to detect a 
considerable 19F signal, even with a scan of only 2 h, which is amenable for in vivo MRI.
Discussion
In this study we show first 19F MR images obtained with a 19F-CRP driven in quadrature mode. Compared to the 
19F/1H RT-coil we previously developed11, we show that the 19F-CRP facilitates superior ex vivo images of brain 
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Figure 3. Comparison of SNR between the 19F-CRP and 19F/1H RT-coil. (A) Cross-sectional spin-echo 19F MR 
images of a TFE phantom acquired with the RT RF coil (left) and the CRP (right). The CRP showed a spatially 
varying sensitivity that is typical for transceive surface coils. (B) Plots of the SNR profile along the vertical 
axis at the center of the phantom. For the RT volume resonator (red curve) the SNR was very uniform within 
the phantom. In contrast, for the CRP the SNR drops rapidly with increasing distance to the RF coil. For this 
particular reference pulse power, SNR reached its maximum at 2.4 mm from the CRP surface, where it is 15-fold 
higher than the SNR of the RT coil. Beyond a distance of 8.1 mm the 19F-CRP did not provide any SNR gain with 
regard to the 19F/1H RT-coil.
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inflammation in an animal model of MS. At the current stage of development the 19F-CRP cannot yet be employed 
for in vivo imaging due to incompatibilities with conventional 1H RT coils, as discussed later. Nevertheless the 
results are encouraging, and offer proof-of-concept demonstration of the potential for this technology.
After introducing the concept of cryogenically-cooled RF coil hardware to reduce thermal noise and thus 
increase SNR46, CRP technologies were developed for small animal MRI, particularly for anatomical 1H MRI of 
mouse brain41, 47–50. Introducing a quadrature CRP design, enabled further SNR gains (~2.5) at 400 MHz24, 25 com-
pared to RT coils with similar geometries. The SNR gain prediction for the 19F-CRP is expected to be equivalent 
due to the close Larmor frequency (376 MHz at 9.4T).
The potential applications of 19F MR methods to image inflammation have long been recognized11–17. 
For several years, neuroinflammation has been studied using gadolinium-based contrast agents. However, 
gadolinium-enhancing lesions are diffuse, and lack spatial precision. Improvements have been realized with the 
use of alternative contrast agents, such iron oxide nanoparticles, although their effects on magnetic susceptibility 
limit their discrimination from endogenous confounding artifacts. 19F MR methods abrogate this, since 19F sig-
nals derive exclusively from exogenously applied 19F nanoparticles. Efforts have been made to boost 19F signal e.g. 
by promoting 19F nanoparticle cellular uptake20. Nevertheless, major challenges of signal sensitivity constraints 
remain. Improving 19F sensitivity with the 19F-CRP will be essential to realizing the full potential of 19F MR.
Our motivation to investigate the 19F-CRP was to increase the sensitivity to detect neuroinflammation. 
Considering the geometrical differences between both coils, it was imperative to measure SNR at locations below 
the CRP that correspond to the mouse brain, using phantoms spanning the entire coronal view, as a basis for 
future in vivo studies. We performed SNR measurements for both 19F-CRP and control 19F/1H RT-coil using a 
spin echo sequence (RARE), commonly used for 19F MRI due to its high SNR per unit time compared to spoiled 
gradient echo sequences.
The sensitivity of the 19F-CRP is spatially dependent. Given that the CRP is a transceive quadrature surface 
coil array, both transmit field (B1+) and receive sensitivity (B1−) diminish with increasing distance from the RF 
coil – a factor that must be accounted for in quantitative imaging by measuring the actual B1 and correcting the 
signal intensities using the signal equation of the employed pulse sequence. This is absolutely essential when 
signal quantification is necessary in order to ascertain the level of inflammation over the entire region of the 
brain during EAE. Nevertheless, this characteristic is shared by all transceive surface coils. This adverse effect is 
counterbalanced by an SNR gain, up to ~15-fold in the practical comparison made within this study. This SNR 
Figure 4. Comparison of 19F signal sensitivity between 19F-CRP and 19F/1H RT-coil as a function of the number 
of 19F atoms. (A) Cross-sectional spin-echo 19F MR images of 19F nanoparticle phantoms acquired for both CRP 
(middle panel) and RT coil (lower panel). Each 19F MR image indicates an MR scan with a defined number 
of 19F atoms per voxel (upper panel) achieved with different concentrations of PFCE (ranging from 25 mM to 
200 mM) and slice thicknesses varying from 0.4 to 2.0 mm. (B) Estimation of SNR gain provided by the 19F-CRP 
compared to the 19F/1H RT-coil using high PFCE concentrations (200 mM to 1200 mM) and slice thicknesses 
varying from 1.0 to 6.0 mm. Shown is a log-log plot of SNR versus 19F atoms per voxel including a linear fit for 
both CRP (y = 5e−16x) and RT coil (y = 4e−17x).
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gain can be attributed to factors including cooling (in the range of 2–3 for 1H24, 25), differences in RF coil design 
(birdcage vs. surface coil; quadrature versus linear), RF coil sample loading, and the specific RF pulse power 
adjustments. Here, pulse power was adjusted in order to avoid substantial signal loss at the dorsal part of the 
brain, which is observed when using a RARE sequence with excessive RF power. Predicting the sensitivity and 
detection limits of 19F measurements for specific hardware setups51 will help facilitate further 19F-CRP studies 
with other fluorinated compounds.
An SNR gain of 15 can be exploited in several ways — by reducing scan time by a factor 225 (e.g. from 1 h to 
~15 s), or doubling 3D spatial resolution (e.g. from 600 µm to 300 µm) while still gaining SNR (~2.5). In this study 
we made use of the superior SNR, employing isotropic spatial resolutions of 150 μm to study neuroinflammation. 
Using the 19F-CRP at this resolution, we gained more precise information regarding inflammatory cell localization 
in the brain, compared to our previous study11. The 19F MR images with the CRP showed excellent correspond-
ence with the typical pattern of histopathology39, 40. A robust accumulation of inflammatory lesions, especially 
in the white matter tracts of the cerebellum, is a hallmark of EAE in SJL mice, which we also observed in our 
prior studies using high resolution 1H MR41, 42 and low resolution 19F MR11. The pathology also extends into the 
cerebrum, as shown both prior to the occurrence of clinical symptoms (Supplementary Figure) and also during 
ongoing clinical disease (Figs 5 and 6). The 19F-CRP MR images also enabled discrimination of extraparenchymal 
meningeal inflammation, consistent with recent reports highlighting the relevance of inflammatory cell traffick-
ing via the blood meningeal barrier43, 44 and extravasation via leptomeningeal microvessels into the subarach-
noid space45. This also reflects the situation in MS3–5. Recent studies have argued for the presence of a lymphatic 
circulation in the meninges in association with these vessels, capable of draining immune cells from meningeal 
spaces8 and brain parenchyma7 into deep cervical lymph nodes. Therefore, the capacity to perform non-invasive 
longitudinal investigations with fidelity 19F MRI to monitor the dynamics and distribution of infiltrating immune 
cells will be directly relevant for experimental neuroimmunologists.
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Figure 5. High spatial resolution 19F MR image of an ex vivo brain from an EAE mouse showing clinical 
disease. With both 19F-CRP and 19F/1H RT-coil, 19F MR images were acquired using a 3D-RARE sequence. 
19F MR images (shown in red) were combined with 1H MR images (shown in grayscale). 1H MR images were 
acquired using a 3D-FLASH sequence and the 19F/1H RT-coil. (A) Three exemplary slices from horizontal views 
of combined 19F/1H MR images for both 19F/1H RT-coil (upper panel) and 19F-CRP (middle panel), in the lower 
panel a 300% zoom of the 19F/1H MR images acquired with the CRP. (B) Three exemplary slices from coronal 
views of combined 19F/1H MR images for both RT coil (upper panel) and CRP (middle panel). Registration of the 
Allen brain atlas to the 1H image (lower panel) shows following labelled brain regions: rs: retrosplenial area; crn: 
cranial nerves; sc: superior colliculus (sensory related); pmv: posteromedial visual area; ps: postsubiculum; av: 
arbor vitae; cbn: cerebellar nuclei. (C) 3-D rendering of the combined 19F/1H MR images for both 19F/1H RT-coil 
(upper panel) and 19F-CRP (lower panel).
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The gradient in the B1 field of the 19F-CRP leads to a gradual decline in 19F MR signal with increasing distance 
from the probe head. This results in reduced signal in ventral regions. Studies of the EAE model are, in general, 
more focused on imaging of the CNS, and less so on imaging of the superficial lymph nodes. When imaging of 
the lymph nodes in the ventral regions is necessary, one could consider measuring the mouse brain in the supine 
and prone positions, in order to ensure coverage of the dorsal sides comprising the whole brain as well as ventral 
sides to include the draining lymph nodes. Other possible workarounds include adding an anterior 19F RT RF 
coil to the mouse bed or combining 19F images from RT and CRP. These approaches could help to overcome this 
inherent limitation of the 19F-CRP, while still utilizing its superior SNR. While the spatial dependency poses a 
constraint for studies investigating the involvement of the draining lymph nodes, the translational applications 
of the 19F-CRP are not limited to EAE. The 19F-CRP will also be useful for studying brain inflammation in animal 
models of tumour growth (especially those tumours implanted in the cortex or striatum), and studies on the 
middle cerebral artery occlusion model of stroke. Inflammation in these preclinical models could readily be 
imaged, since the focus of pathology in these models is located in regions where the 19F-CRP clearly outperforms 
the 19F/1H RT-coil.
In vivo 19F MRI studies require acquisition of anatomical 1H MR images within a reasonable time frame. A 
dual-tunable RF probe would be most ideal, in order to avoid inaccurate co-registration of both signals52. Despite 
the clear improvement in SNR of the 19F-CRP, the quadrature design prohibits the presence of a dual resonant 
MR signal that would be needed for anatomical 1H MRI. Furthermore conventional 1H RF resonators cannot be 
used in combination with the 19F-CRP due to coupling between both RF coils. To avoid this, the 19F-CRP would 
need to be removed while the in vivo 1H images are acquired. This would cause changes in the alignment of the 
mouse within the scanner during in vivo measurements that are serious enough to constitute a major hindrance. 
Even with the use of reference markers, any slight shift in the position of the markers with respect to the mouse 
during the procedure will result in an incorrect registration between 19F and 1H images. The current procedure of 
registering the 19F images of the CRP with those of the RT RF coil is complicated and time consuming, requires 
sufficient SNR and is an impediment for in vivo experiments. A proposed solution to this limitation could be 
to construct an anterior 1H RT RF coil, specifically designed to be added to the mouse bed while the 19F-CRP 
remains installed, in order to provide anatomical guidance. A dual-tunable 1H/19F RT RF coil would also take into 
account the above approach (implementation of a 19F RF-coil below the mouse head).
This study presents the first demonstration of the performance of a quadrature 19F-CRP tailored for small 
rodents, showing superior SNR and 19F MR image quality. The logical extension of this work will be to translate 
these results into in vivo studies, such as those studying pathological changes during neuroinflammatory disease. 
While the results of the current study are highly encouraging, a challenging road still lies ahead for the application 
of the 19F-CRP in in vivo studies. Previous studies using 19F MR have been seriously hampered by the low SNR, 
and compensating for this limitation by using low spatial resolution has generally yielded images with rather poor 
definition, and therefore limited scientific utility. The current study aims to improve this situation, bringing 19F 
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Figure 6. High spatial resolution 19F MRI using acquisition times feasible for in vivo imaging. 19F MR images 
were acquired with the 19F-CRP using acquisition times between 30 min and 11 h. The 19F images were scaled to 
units of SNR, thresholded at SNR = 4, and overlayed onto the 1H MR images using a pseudocolor scale.
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MR imaging a step closer to the objective of ‘microscopic MRI’. Our results showed a remarkable SNR and detail 
of neuroinflammation, compared to conventional 19F MRI, heralding a bright potential for the application of 
19F-CRP for non-invasive MRI in vivo.
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